Calcium Gluconate Production Costs - Q2 2023
Calcium Gluconate Operating Costs & Plants Capital Investment
Calcium Gluconate is a mineral supplement and medication. Supplementation may be done to treat or prevent osteoporosis or rickets, consequences of calcium deficiency. It can also be taken by mouth, but it is not recommended by injection into a muscle. For calcium therapy, Calcium Gluconate is a well established and the most accepted drug in the medical field. Calcium in its ionic form has been shown to be an excellent therapeutic agent for the treatment of diseases caused and aggravated by deficiency of Calcium in the body.
Intratec offers professional, easy-to-understand reports examining Calcium Gluconate production costs. Each study describes an industrial plant, including main process units and site infrastructure, and presents an independent analysis of capital and operating costs. All reports are based on the most recent economic data available (Q2 2023).
Calcium Gluconate Production
This report presents the economics of a typical Calcium Gluconate production process from glucose, sodium bromide, and calcium carbonate in the United States. Initially, glucose dissolved in a sodium bromide solution is electrolyzed and is oxidized to gluconic acid. The resulting acid is then neutralized by calcium carbonate, producing calcium gluconate.
Details: 30 kta United States-based plant | Q2 2023 | 107 pages From $1,999 USD
The cost analyses presented in the report Calcium Gluconate E11A target a 30 kta (kilometric tons per annum) United States-based plant. For those interested in cost analyses considering other plant capacities and/or locations, Intratec offers a customized analysis as an optional feature.
Could Not Find the Production Cost Report you Need?
If none of the Calcium Gluconate reports listed above fits your needs, you can request a bespoke report examining the process you are interested in! You will have a report tailored to your needs, in which you defined production process, industrial plant capacity and location!
Details: Customer-defined Plant Location & Capacity | Q2 2023 From $2,900 USD
Customers Who Bought This Report Also Bought
Caffeine Production from Tea Waste
This report presents the economics of a typical Caffeine production process from tea leaves waste in the United States via an extraction process.
Details: 1.20 kta United States-based plant | Q2 2023 | 107 pages From $1,999 USD
The cost analyses presented in the report caffeine e11a target a 1.20 kta (kilometric tons per annum) United States-based plant. For those interested in cost analyses considering other plant capacities and/or locations, Intratec offers a customized analysis as an optional feature.
Nicotinamide Production
This report presents the economics of Nicotinamide production from 2-methyl-1,5-pentanediamine (MPDA) in the United States. Initially, MPDA undergoes cyclic hydrogenation that gives 3-methylpiperidine. This compound is then dehydrogenated, yielding 3-methylpyridine, which reacts with ammonia to form 3-cyanopyridine. Finally, it is hydrolyzed to nicotinamide.
Details: 13 kta United States-based plant | Q2 2023 | 107 pages From $1,999 USD
The cost analyses presented in the report Nicotinamide E11A target a 13 kta (kilometric tons per annum) United States-based plant. For those interested in cost analyses considering other plant capacities and/or locations, Intratec offers a customized analysis as an optional feature.
Feed-Grade Riboflavin Production
This report presents the economics of feed-grade Riboflavin production via a typical direct fermentation process using glucose as carbon source in the United States. In the process examined, Riboflavin is produced by fermentation of a glucose syrup. After fermentation, the broth is pasteurized for the inactivation of the microorganisms, Riboflavin is recovered by centrifugation, subjected to a mineral acid treatment, dried and packed. The final product obtained is 96 wt% Riboflavin (feed-grade).
Details: 1 kta United States-based plant | Q2 2023 | 108 pages From $1,999 USD
The cost analyses presented in the report Riboflavin E11A target a 1 kta (kilometric tons per annum) United States-based plant. For those interested in cost analyses considering other plant capacities and/or locations, Intratec offers a customized analysis as an optional feature.
Use our Reports as
Feasibility Studies
Techno-economic Evaluations
Investment Analyses
Multi-regional Cost Analyses
Trusted By
